26/1/2012

Latin America's largest international pharma executive convention

Latin America is the new hotspot for the multinational pharma industry. With innovative scientific discovery, a thriving generic drugs market and dynamic clinical trial landscape, markets such as Brazil, Mexico and Argentina are offering huge new opportunities for growth. Drug companies and their vendors are coming to BioPharma LatAm 2012 to access the market and secure new business throughout the region. Make sure you attend to improve your market access to Latin American markets and collaborate with the regional drug companies driving the industry.


The BioPharma LatAm Convention features three exciting conference programs:

•Drug Discovery World LatAm
•World Generics Congress LatAm
•World Pharma Trials LatAm

Ten reasons to attend:

1. Understand critical success factors for market access in Brazil, Mexico,Venezuela and more
2. Learn how to overcome logistical challenges to access the LatAm pharma Market
3. Get a region-wide understanding of the IP and regulatory landscapes for generic and new drugs
4. Identify key stakeholders for regional partnerships
5. Find out how to conduct global-standard clinical trials in Latin America
6. Maximize your patient recruitment strategies for LatAm clinical trials
7. Effectively divide your resources in Latin America to capitalize on both the generics and innovative drug discovery markets
8. Identify new technologies coming out of the region
9. Be the first to partner with local scientists driving new drug development
10. Improve your local marketing knowledge to boost generic drug sales throughout LatAm

For more information: BioPharma LatAm Convention 2012


Fonte: Michael Murphy (Terrapinn Inc., USA)